Assignee
ETUBICS CORP
US17 patents
Top patents by PatentIndex Score
US10695417B2Jun 30, 2020
Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
ETUBICS CORP9 citations83
US10563224B2Feb 18, 2020
Replication defective adenovirus vector in vaccination
ETUBICS CORP5 citations83
US11389521B2Jul 19, 2022
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP3 citations82
US11376316B2Jul 5, 2022
Breast cancer vaccines and methods of use thereof
ETUBICS CORP3 citations82
US11369673B2Jun 28, 2022
HPV vaccines and methods of use thereof
ETUBICS CORP3 citations82
US11344613B2May 31, 2022
Sequential administration of a replication defective adenovirus vector in vaccination protocols
ETUBICS CORP3 citations82
US11104916B2Aug 31, 2021
Compositions and methods for alphavirus vaccination
ETUBICS CORP6 citations82
US11826417B2Nov 28, 2023
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP1 citations71
US11529408B2Dec 20, 2022
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP1 citations71
US11504423B2Nov 22, 2022
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP2 citations71
US11149087B2Oct 19, 2021
Methods and compositions for combination immunotherapy
ETUBICS CORP2 citations71
US10835596B2Nov 17, 2020
Compositions and methods for flavivirus vaccination
ETUBICS CORP2 citations71
US12370250B2Jul 29, 2025
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP0 citations61
US11352642B2Jun 7, 2022
Methods and compositions for combination immunotherapy
ETUBICS CORP1 citations61
US11304998B2Apr 19, 2022
Combination immunotherapies comprising IL-15 superagonists
ETUBICS CORP1 citations60
US11116827B2Sep 14, 2021
Compositions and methods for tumor vaccination and immunotherapy involving HER antigens
ETUBICS CORP1 citations60
US11020467B2Jun 1, 2021
Combination immunotherapies comprising IL-15 superagonists
ETUBICS CORP1 citations60